Benefits of intensive lipid lowering in patients with stable CHD and systolic blood pressure above or below 140 mmHg: A post hoc analysis of the TNT study

被引:0
|
作者
Kostis, J. [1 ]
Breazna, A. [2 ]
Deedwania, P. [3 ,4 ]
LaRosa, J. [5 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[2] Pfizer Inc, New York, NY USA
[3] UCSF, Sch Med, Fresno, CA USA
[4] VA Cent Calif Healthcare Syst, Fresno, CA USA
[5] SUNY Hlth Sci Ctr, New York, NY USA
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:S27 / S28
页数:2
相关论文
共 50 条
  • [1] The Benefits of Intensive Lipid Lowering in Patients With Stable Coronary Heart Disease With Normal or High Systolic Blood Pressure: An Analysis of the Treating to New Targets (TNT) Study
    Kostis, John B.
    Breazna, Andrei
    Deedwania, Prakash C.
    LaRosa, John C.
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (05): : 367 - 376
  • [2] Cardiovascular events with blood pressure lowering in patients with diabetes and systolic blood pressure below 140 mm Hg
    Salam, Abdul
    Rodgers, Anthony
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2019, 21 (05): : 689 - 689
  • [3] Response to: Cardiovascular events with blood pressure lowering in patients with diabetes and systolic blood pressure below 140 mm Hg
    Wang, Shifei
    Bin, Jianping
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2019, 21 (05): : 690 - 691
  • [5] Further Post-hoc Analysis on Intensive Blood Pressure Lowering in Cerebral Hemorrhage
    Klein, Jan Philipp
    [J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2022, 90 (03) : 86 - 87
  • [6] Evaluating the Benefit of Intensive Blood Pressure Lowering Based on Individual Outcome Profile: Post-hoc Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)
    Shi, S.
    Gouskova, N.
    Wei, L.
    Kim, D. H.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 : S85 - S86
  • [7] Does Post-Randomization Diuretics Use Account for the Cardiovascular Benefits of Intensive Systolic Blood Pressure Lowering in the Systolic Blood Pressure Intervention Trial (SPRINT)?
    Bansal, Shweta
    Boucher, Robert E.
    Wei, Guo
    Chertow, Glenn
    Whelton, Paul K.
    Cheung, Alfred K.
    Shen, Jincheng
    Beddhu, Srinivasan
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 526 - 526
  • [8] Safety and efficacy of intensive systolic blood pressure lowering after successful endovascular therapy: a post hoc analysis of the BP TARGET trial
    Anadani, Mohammad
    Maier, Benjamin
    Escalard, Simon
    Labreuche, Julien
    de Havenon, Adam
    Sabben, Candice
    Lapergue, Bertrand
    Mistry, Eva A.
    Gory, Benjamin
    Spiotta, Alejandro M.
    Richard, Sebastien
    Sibon, Igor
    Desilles, Jean-Philippe
    Blanc, Raphael
    Piotin, Michel
    Mazighi, Mikael
    [J]. JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2023, 15 (E1) : E142 - E147
  • [9] Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention Trial
    Dae Hyun Kim
    Curtis Tatsuoka
    Zhengyi Chen
    Jackson T. Wright
    Michelle C. Odden
    Srinivasan Beddhu
    Brandon K. Bellows
    Adam Bress
    Thaddeus Carson
    William C. Cushman
    Karen C. Johnson
    Donald E. Morisky
    Henry Punzi
    Leonardo Tamariz
    Song Yang
    Lee-Jen Wei
    [J]. Journal of General Internal Medicine, 2022, 37 : 3797 - 3804
  • [10] Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention Trial
    Kim, Dae Hyun
    Tatsuoka, Curtis
    Chen, Zhengyi
    Wright, Jackson T.
    Odden, Michelle C.
    Beddhu, Srinivasan
    Bellows, Brandon K.
    Bress, Adam
    Carson, Thaddeus
    Cushman, William C.
    Johnson, Karen C.
    Morisky, Donald E.
    Punzi, Henry
    Tamariz, Leonardo
    Yang, Song
    Wei, Lee-Jen
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2022, 37 (15) : 3797 - 3804